Epiproteome profiling of cadmium‐transformed human bronchial epithelial cells by quantitative histone post‐translational modification–enzyme‐linked immunosorbent assay
Cadmium (Cd), a carcinogenic toxic metal, is pervasively distributed in the soil, water and air. Chronic exposure to Cd has been correlated to lung disease development including cancers. Although many studies have been conducted to investigate the proteome response of cells challenged with Cd, the e...
Saved in:
Published in | Journal of applied toxicology Vol. 38; no. 6; pp. 888 - 895 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.06.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Cadmium (Cd), a carcinogenic toxic metal, is pervasively distributed in the soil, water and air. Chronic exposure to Cd has been correlated to lung disease development including cancers. Although many studies have been conducted to investigate the proteome response of cells challenged with Cd, the epiproteomic responses (i.e., global histone post‐translational modifications [PTMs]), particularly in human lung cells, are largely unexplored. Here, we provide an epiproteome profiling of human bronchial epithelial cells (BEAS‐2B) chronically treated with cadmium chloride (CdCl2), with the aim of identifying global epiproteomic signatures in response to Cd epigenotoxicity. Total histone proteins from Cd‐treated and untreated BEAS‐2B cells were isolated and subject to quantitative histone PTM–enzyme‐linked immunosorbent assay using 18 histone PTM antibodies. Our results unveiled that chronic Cd treatment led to the marked downregulation of H3K4me2 and H3K36me3 and upregulation of H3K9acS10ph, H4K5ac, H4K8ac and H4K12ac PTM marks. Cd‐treated cells exhibit transformed cell properties as evidenced by enhanced cell migration and the ability of anchorage‐independent growth on soft agar. Notably, treatment of Cd‐transformed cells with C646, a potent histone acetyltransferase inhibitor, suppressed the expression of mesenchymal marker genes and cell migration ability of these cells. Taken together, our studies provide for the first time the global epiproteomic interrogation of chronic Cd‐exposed human lung cells. The identified aberrant histone PTM alterations associated with Cd‐induced epigenotoxicity likely account for the epithelial−mesenchymal transition and neoplastic survival of these cells.
Here, we provide an epiproteome profiling of human lung cells chronically treated with cadmium chloride (CdCl2), with the aim of identifying global epiproteomic signatures associated with Cd‐induced epigenotoxicity. Notably, among the 18 histone post‐translational modification marks examined, a marked decrease of the levels of histone H3K4me2 and H3K36me3 and increase of H3K9acS10ph, H4K5ac, H4K8ac and H4K12ac were found in chronic Cd‐exposed cells. These differential post‐translational modification marks might likely govern the epithelial−mesenchymal transition and neoplastic survival of these cells. |
---|---|
AbstractList | Cadmium (Cd), a carcinogenic toxic metal, is pervasively distributed in the soil, water and air. Chronic exposure to Cd has been correlated to lung disease development including cancers. Although many studies have been conducted to investigate the proteome response of cells challenged with Cd, the epiproteomic responses (i.e., global histone post-translational modifications [PTMs]), particularly in human lung cells, are largely unexplored. Here, we provide an epiproteome profiling of human bronchial epithelial cells (BEAS-2B) chronically treated with cadmium chloride (CdCl2 ), with the aim of identifying global epiproteomic signatures in response to Cd epigenotoxicity. Total histone proteins from Cd-treated and untreated BEAS-2B cells were isolated and subject to quantitative histone PTM-enzyme-linked immunosorbent assay using 18 histone PTM antibodies. Our results unveiled that chronic Cd treatment led to the marked downregulation of H3K4me2 and H3K36me3 and upregulation of H3K9acS10ph, H4K5ac, H4K8ac and H4K12ac PTM marks. Cd-treated cells exhibit transformed cell properties as evidenced by enhanced cell migration and the ability of anchorage-independent growth on soft agar. Notably, treatment of Cd-transformed cells with C646, a potent histone acetyltransferase inhibitor, suppressed the expression of mesenchymal marker genes and cell migration ability of these cells. Taken together, our studies provide for the first time the global epiproteomic interrogation of chronic Cd-exposed human lung cells. The identified aberrant histone PTM alterations associated with Cd-induced epigenotoxicity likely account for the epithelial-mesenchymal transition and neoplastic survival of these cells.Cadmium (Cd), a carcinogenic toxic metal, is pervasively distributed in the soil, water and air. Chronic exposure to Cd has been correlated to lung disease development including cancers. Although many studies have been conducted to investigate the proteome response of cells challenged with Cd, the epiproteomic responses (i.e., global histone post-translational modifications [PTMs]), particularly in human lung cells, are largely unexplored. Here, we provide an epiproteome profiling of human bronchial epithelial cells (BEAS-2B) chronically treated with cadmium chloride (CdCl2 ), with the aim of identifying global epiproteomic signatures in response to Cd epigenotoxicity. Total histone proteins from Cd-treated and untreated BEAS-2B cells were isolated and subject to quantitative histone PTM-enzyme-linked immunosorbent assay using 18 histone PTM antibodies. Our results unveiled that chronic Cd treatment led to the marked downregulation of H3K4me2 and H3K36me3 and upregulation of H3K9acS10ph, H4K5ac, H4K8ac and H4K12ac PTM marks. Cd-treated cells exhibit transformed cell properties as evidenced by enhanced cell migration and the ability of anchorage-independent growth on soft agar. Notably, treatment of Cd-transformed cells with C646, a potent histone acetyltransferase inhibitor, suppressed the expression of mesenchymal marker genes and cell migration ability of these cells. Taken together, our studies provide for the first time the global epiproteomic interrogation of chronic Cd-exposed human lung cells. The identified aberrant histone PTM alterations associated with Cd-induced epigenotoxicity likely account for the epithelial-mesenchymal transition and neoplastic survival of these cells. Cadmium (Cd), a carcinogenic toxic metal, is pervasively distributed in the soil, water and air. Chronic exposure to Cd has been correlated to lung disease development including cancers. Although many studies have been conducted to investigate the proteome response of cells challenged with Cd, the epiproteomic responses (i.e., global histone post‐translational modifications [PTMs]), particularly in human lung cells, are largely unexplored. Here, we provide an epiproteome profiling of human bronchial epithelial cells (BEAS‐2B) chronically treated with cadmium chloride (CdCl2), with the aim of identifying global epiproteomic signatures in response to Cd epigenotoxicity. Total histone proteins from Cd‐treated and untreated BEAS‐2B cells were isolated and subject to quantitative histone PTM–enzyme‐linked immunosorbent assay using 18 histone PTM antibodies. Our results unveiled that chronic Cd treatment led to the marked downregulation of H3K4me2 and H3K36me3 and upregulation of H3K9acS10ph, H4K5ac, H4K8ac and H4K12ac PTM marks. Cd‐treated cells exhibit transformed cell properties as evidenced by enhanced cell migration and the ability of anchorage‐independent growth on soft agar. Notably, treatment of Cd‐transformed cells with C646, a potent histone acetyltransferase inhibitor, suppressed the expression of mesenchymal marker genes and cell migration ability of these cells. Taken together, our studies provide for the first time the global epiproteomic interrogation of chronic Cd‐exposed human lung cells. The identified aberrant histone PTM alterations associated with Cd‐induced epigenotoxicity likely account for the epithelial−mesenchymal transition and neoplastic survival of these cells. Here, we provide an epiproteome profiling of human lung cells chronically treated with cadmium chloride (CdCl2), with the aim of identifying global epiproteomic signatures associated with Cd‐induced epigenotoxicity. Notably, among the 18 histone post‐translational modification marks examined, a marked decrease of the levels of histone H3K4me2 and H3K36me3 and increase of H3K9acS10ph, H4K5ac, H4K8ac and H4K12ac were found in chronic Cd‐exposed cells. These differential post‐translational modification marks might likely govern the epithelial−mesenchymal transition and neoplastic survival of these cells. Cadmium (Cd), a carcinogenic toxic metal, is pervasively distributed in the soil, water and air. Chronic exposure to Cd has been correlated to lung disease development including cancers. Although many studies have been conducted to investigate the proteome response of cells challenged with Cd, the epiproteomic responses (i.e., global histone post‐translational modifications [PTMs]), particularly in human lung cells, are largely unexplored. Here, we provide an epiproteome profiling of human bronchial epithelial cells (BEAS‐2B) chronically treated with cadmium chloride (CdCl 2 ), with the aim of identifying global epiproteomic signatures in response to Cd epigenotoxicity. Total histone proteins from Cd‐treated and untreated BEAS‐2B cells were isolated and subject to quantitative histone PTM–enzyme‐linked immunosorbent assay using 18 histone PTM antibodies. Our results unveiled that chronic Cd treatment led to the marked downregulation of H3K4me2 and H3K36me3 and upregulation of H3K9acS10ph, H4K5ac, H4K8ac and H4K12ac PTM marks. Cd‐treated cells exhibit transformed cell properties as evidenced by enhanced cell migration and the ability of anchorage‐independent growth on soft agar. Notably, treatment of Cd‐transformed cells with C646, a potent histone acetyltransferase inhibitor, suppressed the expression of mesenchymal marker genes and cell migration ability of these cells. Taken together, our studies provide for the first time the global epiproteomic interrogation of chronic Cd‐exposed human lung cells. The identified aberrant histone PTM alterations associated with Cd‐induced epigenotoxicity likely account for the epithelial−mesenchymal transition and neoplastic survival of these cells. Here, we provide an epiproteome profiling of human lung cells chronically treated with cadmium chloride (CdCl 2 ), with the aim of identifying global epiproteomic signatures associated with Cd‐induced epigenotoxicity. Notably, among the 18 histone post‐translational modification marks examined, a marked decrease of the levels of histone H3K4me2 and H3K36me3 and increase of H3K9acS10ph, H4K5ac, H4K8ac and H4K12ac were found in chronic Cd‐exposed cells. These differential post‐translational modification marks might likely govern the epithelial−mesenchymal transition and neoplastic survival of these cells. Cadmium (Cd), a carcinogenic toxic metal, is pervasively distributed in the soil, water and air. Chronic exposure to Cd has been correlated to lung disease development including cancers. Although many studies have been conducted to investigate the proteome response of cells challenged with Cd, the epiproteomic responses (i.e., global histone post-translational modifications [PTMs]), particularly in human lung cells, are largely unexplored. Here, we provide an epiproteome profiling of human bronchial epithelial cells (BEAS-2B) chronically treated with cadmium chloride (CdCl ), with the aim of identifying global epiproteomic signatures in response to Cd epigenotoxicity. Total histone proteins from Cd-treated and untreated BEAS-2B cells were isolated and subject to quantitative histone PTM-enzyme-linked immunosorbent assay using 18 histone PTM antibodies. Our results unveiled that chronic Cd treatment led to the marked downregulation of H3K4me2 and H3K36me3 and upregulation of H3K9acS10ph, H4K5ac, H4K8ac and H4K12ac PTM marks. Cd-treated cells exhibit transformed cell properties as evidenced by enhanced cell migration and the ability of anchorage-independent growth on soft agar. Notably, treatment of Cd-transformed cells with C646, a potent histone acetyltransferase inhibitor, suppressed the expression of mesenchymal marker genes and cell migration ability of these cells. Taken together, our studies provide for the first time the global epiproteomic interrogation of chronic Cd-exposed human lung cells. The identified aberrant histone PTM alterations associated with Cd-induced epigenotoxicity likely account for the epithelial-mesenchymal transition and neoplastic survival of these cells. Cadmium (Cd), a carcinogenic toxic metal, is pervasively distributed in the soil, water and air. Chronic exposure to Cd has been correlated to lung disease development including cancers. Although many studies have been conducted to investigate the proteome response of cells challenged with Cd, the epiproteomic responses (i.e., global histone post‐translational modifications [PTMs]), particularly in human lung cells, are largely unexplored. Here, we provide an epiproteome profiling of human bronchial epithelial cells (BEAS‐2B) chronically treated with cadmium chloride (CdCl2), with the aim of identifying global epiproteomic signatures in response to Cd epigenotoxicity. Total histone proteins from Cd‐treated and untreated BEAS‐2B cells were isolated and subject to quantitative histone PTM–enzyme‐linked immunosorbent assay using 18 histone PTM antibodies. Our results unveiled that chronic Cd treatment led to the marked downregulation of H3K4me2 and H3K36me3 and upregulation of H3K9acS10ph, H4K5ac, H4K8ac and H4K12ac PTM marks. Cd‐treated cells exhibit transformed cell properties as evidenced by enhanced cell migration and the ability of anchorage‐independent growth on soft agar. Notably, treatment of Cd‐transformed cells with C646, a potent histone acetyltransferase inhibitor, suppressed the expression of mesenchymal marker genes and cell migration ability of these cells. Taken together, our studies provide for the first time the global epiproteomic interrogation of chronic Cd‐exposed human lung cells. The identified aberrant histone PTM alterations associated with Cd‐induced epigenotoxicity likely account for the epithelial−mesenchymal transition and neoplastic survival of these cells. |
Author | Wu, Dan‐Dan Liang, Zhan‐Ling Yang, Lei Lau, Andy T. Y. Yao, Yue Xu, Yan‐Ming Tan, Heng Wee Rots, Marianne G. Yu, Fei‐Yuan Hylkema, Machteld N. |
Author_xml | – sequence: 1 givenname: Zhan‐Ling surname: Liang fullname: Liang, Zhan‐Ling organization: Shantou University Medical College – sequence: 2 givenname: Dan‐Dan surname: Wu fullname: Wu, Dan‐Dan organization: University Medical Center Groningen, University of Groningen – sequence: 3 givenname: Yue surname: Yao fullname: Yao, Yue organization: Shantou University Medical College – sequence: 4 givenname: Fei‐Yuan surname: Yu fullname: Yu, Fei‐Yuan organization: Shantou University Medical College – sequence: 5 givenname: Lei surname: Yang fullname: Yang, Lei organization: Shantou University Medical College – sequence: 6 givenname: Heng Wee surname: Tan fullname: Tan, Heng Wee organization: Shantou University Medical College – sequence: 7 givenname: Machteld N. orcidid: 0000-0002-6732-8903 surname: Hylkema fullname: Hylkema, Machteld N. organization: University Medical Center Groningen, University of Groningen – sequence: 8 givenname: Marianne G. orcidid: 0000-0002-7416-2788 surname: Rots fullname: Rots, Marianne G. organization: University Medical Center Groningen, University of Groningen – sequence: 9 givenname: Yan‐Ming orcidid: 0000-0003-1124-0045 surname: Xu fullname: Xu, Yan‐Ming email: amyymxu@stu.edu.cn organization: Shantou University Medical College – sequence: 10 givenname: Andy T. Y. orcidid: 0000-0002-7146-7789 surname: Lau fullname: Lau, Andy T. Y. email: andytylau@stu.edu.cn organization: Shantou University Medical College |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29423916$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kctu1DAUhi1URKcFiSdAltiwyXDs3JdVVQqoEpsisYsc54TxENup7YDSVR8BiQfhnfokODMdkBCsfKzzndv_n5AjYw0S8pzBmgHw11sR1mlel4_IikFdJ4wX6RFZAS8gydLy0zE58X4LEHO8ekKOeZ3xtGbFivy8GNXobECrkcagV4Myn6ntqRSdVpO-v_senDC-t05jRzeTFoa2zhq5UWKgOKqwwWEJJQ6Dp-1MbyZhggoiqK9IN8qHuCwdrQ-HXkNMWRNLtO1Ur-Tue3_3A83trDFScYcvcZjSejLWW9eiCVR4L-an5HEvBo_PHt5T8vHNxfX52-Tqw-W787OrRKZVWiYVywXKtIScVzWvuezSFESWoYQCEXPZdUXVtXmRt7xjGUAmMg59zQQvpQBMT8mrfd-oyc2EPjRa-eVCYdBOvuEADIqC1XlEX_6Fbu3k4nkLxfMaSoAiUi8eqKmNQjajU1q4uTlYEYH1HpDOeu-wb-ROQ2uiZmpoGDSL1030ulm8_rPi74JDz3-gyR79pgac_8s178-ud_wvISDBFw |
CitedBy_id | crossref_primary_10_1186_s12935_022_02638_3 crossref_primary_10_1007_s44169_023_00042_0 crossref_primary_10_1007_s10565_020_09560_2 crossref_primary_10_3390_ijms222111399 crossref_primary_10_1016_j_taap_2021_115756 crossref_primary_10_1016_j_tiv_2019_104630 crossref_primary_10_3390_cancers12040974 crossref_primary_10_1039_c9tx00126c crossref_primary_10_3390_cells8080842 crossref_primary_10_1016_j_taap_2022_116070 crossref_primary_10_1007_s11356_021_12985_9 crossref_primary_10_3390_cancers14235768 crossref_primary_10_1016_j_ecoenv_2022_114311 crossref_primary_10_1016_j_ecoenv_2022_114486 crossref_primary_10_1016_j_jhazmat_2021_126182 crossref_primary_10_1016_j_cbi_2024_111221 crossref_primary_10_3390_biom13030558 crossref_primary_10_3390_genes11080895 crossref_primary_10_3390_ijms23147853 crossref_primary_10_1016_j_fct_2024_114523 crossref_primary_10_1016_j_crtox_2024_100166 crossref_primary_10_1016_j_bbrc_2023_149124 |
Cites_doi | 10.1158/0008-5472.CAN-06-3771 10.1016/j.cell.2011.02.013 10.5271/sjweh.2104 10.18632/oncotarget.6738 10.1093/abbs/gmv099 10.1021/pr401159f 10.1289/ehp.111-1241504 10.1038/nsmb1107-1110 10.1038/nprot.2007.202 10.1093/abbs/gmx022 10.1002/prca.201600059 10.1002/jat.2717 10.1007/s40495-017-0103-4 10.1634/stemcells.2007-0131 10.2353/ajpath.2009.080874 10.1039/C3MT00344B 10.1016/j.envpol.2007.06.012 10.1016/j.reprotox.2017.07.021 10.1016/j.taap.2006.01.011 10.1002/pmic.201300435 10.4161/epi.6.7.16250 10.1016/j.celrep.2014.05.026 |
ContentType | Journal Article |
Copyright | Copyright © 2018 John Wiley & Sons, Ltd. |
Copyright_xml | – notice: Copyright © 2018 John Wiley & Sons, Ltd. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7ST 7TK 7U7 C1K K9. SOI 7X8 |
DOI | 10.1002/jat.3597 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Environment Abstracts Neurosciences Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) Environment Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Toxicology Abstracts Neurosciences Abstracts Environment Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1099-1263 |
EndPage | 895 |
ExternalDocumentID | 29423916 10_1002_jat_3597 JAT3597 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Colleges and Universities Innovation Project of Guangdong Province of China funderid: 2016KTSCX041; 2016KTSCX042 – fundername: Science and Technology Planning Project of Guangdong Province of China funderid: 2016A020215144 – fundername: Department of Education, Guangdong Government under the Top‐tier University Development Scheme for Research and Control of Infectious Diseases – fundername: "Thousand, Hundred, and Ten" Project of the Department of Education of Guangdong Province of China funderid: 124 – fundername: Guangdong Natural Science Foundation of China funderid: 2017A030313131 – fundername: “Yang Fan” Project of Guangdong Province of China funderid: Andy T. Y. Lau‐2016; Yan‐Ming Xu‐2015 – fundername: National Natural Science Foundation of China funderid: 31271445; 31771582 |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AAHQN AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEFU ABEML ABIJN ABJNI ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AI. AIAGR AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR2 DRFUL DRSTM EBD EBS EDH EJD F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA GWYGA H.T H.X HF~ HGLYW HHZ HVGLF HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6Q MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ UB1 V8K VH1 W8V W99 WBFHL WBKPD WH7 WIB WIH WIK WJL WOHZO WQJ WRC WUP WWP WXSBR WYISQ XG1 XPP XV2 YCJ YHZ ZXP ZZTAW ~02 ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7ST 7TK 7U7 C1K K9. SOI 7X8 |
ID | FETCH-LOGICAL-c3837-815aec3705289292cd330a44ec06eee5cdd68db565b2d14004a420f91a27ca0e3 |
IEDL.DBID | DR2 |
ISSN | 0260-437X 1099-1263 |
IngestDate | Fri Jul 11 15:29:38 EDT 2025 Sat Jul 26 02:24:23 EDT 2025 Mon Jul 21 06:05:57 EDT 2025 Tue Jul 01 00:50:03 EDT 2025 Thu Apr 24 23:00:47 EDT 2025 Wed Jan 22 17:00:38 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | acetylation cell transformation epiproteome methylation cadmium human lung cells histone post-translational modifications phosphorylation ELISA |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor Copyright © 2018 John Wiley & Sons, Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3837-815aec3705289292cd330a44ec06eee5cdd68db565b2d14004a420f91a27ca0e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-6732-8903 0000-0003-1124-0045 0000-0002-7146-7789 0000-0002-7416-2788 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jat.3597 |
PMID | 29423916 |
PQID | 2025907006 |
PQPubID | 105373 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2001066195 proquest_journals_2025907006 pubmed_primary_29423916 crossref_citationtrail_10_1002_jat_3597 crossref_primary_10_1002_jat_3597 wiley_primary_10_1002_jat_3597_JAT3597 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | June 2018 2018-06-00 20180601 |
PublicationDateYYYYMMDD | 2018-06-01 |
PublicationDate_xml | – month: 06 year: 2018 text: June 2018 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Bognor Regis |
PublicationSubtitle | JAT |
PublicationTitle | Journal of applied toxicology |
PublicationTitleAlternate | J Appl Toxicol |
PublicationYear | 2018 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2017; 73 1993; 58 2017; 8 2016; 7 2015; 47 2017; 3 2017; 49 1986; 12 2017; 11 2014; 14 2014; 13 2009; 174 2007; 2 2006; 215 2011; 6 2014; 7 2014; 6 2007; 67 2003; 111 2012; 32 2007; 25 2011; 144 2008; 151 2007; 14 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_25_1 e_1_2_7_13_1 e_1_2_7_24_1 e_1_2_7_12_1 e_1_2_7_23_1 e_1_2_7_11_1 e_1_2_7_22_1 e_1_2_7_10_1 e_1_2_7_21_1 International Agency for Research on Cancer (e_1_2_7_9_1) 1993; 58 e_1_2_7_20_1 Rafati Rahimzadeh M. (e_1_2_7_18_1) 2017; 8 |
References_xml | – volume: 14 start-page: 1110 year: 2007 end-page: 1115 article-title: Primers on chromatin publication-title: Nature Structural & Molecular Biology – volume: 111 start-page: 825 year: 2003 end-page: 835 article-title: Genomic and proteomic profiling of responses to toxic metals in human lung cells publication-title: Environmental Health Perspectives – volume: 151 start-page: 362 year: 2008 end-page: 367 article-title: Human health effects of air pollution publication-title: Environmental Pollution – volume: 6 start-page: 587 year: 2014 end-page: 597 article-title: A proteomic approach to investigate the effects of cadmium and lead on human primary renal cells publication-title: Metallomics – volume: 144 start-page: 646 year: 2011 end-page: 674 article-title: Hallmarks of cancer: the next generation publication-title: Cell – volume: 6 start-page: 820 year: 2011 end-page: 827 article-title: Environmental epigenetics in metal exposure publication-title: Epigenetics – volume: 47 start-page: 946 year: 2015 end-page: 949 article-title: Preparation of highly specific polyclonal antibody for human zinc transporter ZIP8 publication-title: Acta Biochimica et Biophysica Sinica – volume: 7 start-page: 6146 year: 2016 end-page: 6158 article-title: Proteome profiling of cadmium‐induced apoptosis by antibody array analyses in human bronchial epithelial cells publication-title: Oncotarget – volume: 11 year: 2017 article-title: Aberrant cytokine secretion and zinc uptake in chronic cadmium‐exposed lung epithelial cells publication-title: Proteomics Clinical Applications – volume: 8 start-page: 135 year: 2017 end-page: 145 article-title: Cadmium toxicity and treatment: An update publication-title: Caspian Journal of Internal Medicine – volume: 49 start-page: 444 year: 2017 end-page: 449 article-title: Progressive silencing of the zinc transporter Zip8 (Slc39a8) in chronic cadmium‐exposed lung epithelial cells publication-title: Acta Biochimica et Biophysica Sinica – volume: 2 start-page: 1445 year: 2007 end-page: 1457 article-title: Extraction, purification and analysis of histones publication-title: Nature Protocols – volume: 32 start-page: 643 year: 2012 end-page: 653 article-title: Epigenetic targets of some toxicologically relevant metals: a review of the literature publication-title: Journal of Applied Toxicology – volume: 58 start-page: 119 year: 1993 end-page: 238 article-title: IARC monographs on the evaluation of the carcinogenic risks to humans. Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry publication-title: IARC – volume: 12 start-page: 523 year: 1986 end-page: 537 article-title: Airborne cadmium and carcinogenesis of the respiratory tract publication-title: Scandinavian Journal of Work, Environment & Health – volume: 13 start-page: 1677 year: 2014 end-page: 1687 article-title: Cd ‐induced alteration of the global proteome of human skin fibroblast cells publication-title: Journal of Proteome Research – volume: 3 start-page: 286 year: 2017 end-page: 293 article-title: Discovering epimodifications of the genome, transcriptome, proteome, and metabolome: the quest for conquering the uncharted epi(c) territories publication-title: Current Pharmacology Reports – volume: 73 start-page: 105 year: 2017 end-page: 127 article-title: The environment and male reproduction: The effect of cadmium exposure on reproductive function and its implication in fertility publication-title: Reproductive Toxicology – volume: 215 start-page: 1 year: 2006 end-page: 8 article-title: Acquired tolerance in cadmium‐adapted lung epithelial cells: roles of the c‐Jun N‐terminal kinase signaling pathway and basal level of metallothionein publication-title: Toxicology & Applied Pharmacology – volume: 25 start-page: 2567 year: 2007 end-page: 2574 article-title: Global epiproteomic signatures distinguish embryonic stem cells from differentiated cells publication-title: Stem Cells – volume: 7 start-page: 2006 year: 2014 end-page: 2018 article-title: SETD2‐dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stability publication-title: Cell Reports – volume: 14 start-page: 2047 year: 2014 end-page: 2060 article-title: Posttranslational modifications of human histone H3: an update publication-title: Proteomics – volume: 174 start-page: 1619 year: 2009 end-page: 1628 article-title: Global levels of histone modifications predict prognosis in different cancers publication-title: American Journal of Pathology – volume: 67 start-page: 2107 year: 2007 end-page: 2113 article-title: The possible role of cytokeratin 8 in cadmium‐induced adaptation and carcinogenesis publication-title: Cancer Research – ident: e_1_2_7_12_1 doi: 10.1158/0008-5472.CAN-06-3771 – ident: e_1_2_7_8_1 doi: 10.1016/j.cell.2011.02.013 – ident: e_1_2_7_15_1 doi: 10.5271/sjweh.2104 – volume: 58 start-page: 119 year: 1993 ident: e_1_2_7_9_1 article-title: IARC monographs on the evaluation of the carcinogenic risks to humans. Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry publication-title: IARC – ident: e_1_2_7_23_1 doi: 10.18632/oncotarget.6738 – ident: e_1_2_7_25_1 doi: 10.1093/abbs/gmv099 – ident: e_1_2_7_17_1 doi: 10.1021/pr401159f – ident: e_1_2_7_2_1 doi: 10.1289/ehp.111-1241504 – ident: e_1_2_7_11_1 doi: 10.1038/nsmb1107-1110 – ident: e_1_2_7_20_1 doi: 10.1038/nprot.2007.202 – ident: e_1_2_7_7_1 doi: 10.1093/abbs/gmx022 – ident: e_1_2_7_22_1 doi: 10.1002/prca.201600059 – ident: e_1_2_7_3_1 doi: 10.1002/jat.2717 – ident: e_1_2_7_24_1 doi: 10.1007/s40495-017-0103-4 – volume: 8 start-page: 135 year: 2017 ident: e_1_2_7_18_1 article-title: Cadmium toxicity and treatment: An update publication-title: Caspian Journal of Internal Medicine – ident: e_1_2_7_4_1 doi: 10.1634/stemcells.2007-0131 – ident: e_1_2_7_19_1 doi: 10.2353/ajpath.2009.080874 – ident: e_1_2_7_6_1 doi: 10.1039/C3MT00344B – ident: e_1_2_7_10_1 doi: 10.1016/j.envpol.2007.06.012 – ident: e_1_2_7_5_1 doi: 10.1016/j.reprotox.2017.07.021 – ident: e_1_2_7_13_1 doi: 10.1016/j.taap.2006.01.011 – ident: e_1_2_7_21_1 doi: 10.1002/pmic.201300435 – ident: e_1_2_7_14_1 doi: 10.4161/epi.6.7.16250 – ident: e_1_2_7_16_1 doi: 10.1016/j.celrep.2014.05.026 |
SSID | ssj0009928 |
Score | 2.3207898 |
Snippet | Cadmium (Cd), a carcinogenic toxic metal, is pervasively distributed in the soil, water and air. Chronic exposure to Cd has been correlated to lung disease... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 888 |
SubjectTerms | Acetylation Airborne particulates Antibodies Bronchi - drug effects Bronchi - metabolism Bronchi - pathology Cadmium Cadmium chloride Cadmium Chloride - toxicity Carcinogens Cell Line Cell migration Cell Movement - drug effects Cell Proliferation - drug effects cell transformation Chronic exposure ELISA Enzyme Inhibitors - pharmacology Enzyme-Linked Immunosorbent Assay Enzymes epiproteome Epithelial cells Epithelial Cells - drug effects Epithelial Cells - metabolism Epithelial Cells - pathology Epithelial-Mesenchymal Transition - drug effects Gene expression histone Histone acetyltransferase Histone Acetyltransferases - antagonists & inhibitors Histone Acetyltransferases - metabolism Histones - metabolism human lung cells Humans Interrogation Lung diseases Mesenchyme Methylation phosphorylation post‐translational modifications Protein Processing, Post-Translational - drug effects Proteins Proteomes Proteomics - methods Soil water Transformed cells Translation |
Title | Epiproteome profiling of cadmium‐transformed human bronchial epithelial cells by quantitative histone post‐translational modification–enzyme‐linked immunosorbent assay |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjat.3597 https://www.ncbi.nlm.nih.gov/pubmed/29423916 https://www.proquest.com/docview/2025907006 https://www.proquest.com/docview/2001066195 |
Volume | 38 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NattAEF5KToHSJumfm7RsobiXyJF2JVk6lpIQCi2hJGDoQeyfwI0luZZ0UE55hEAepO-UJ-nMrmST_kDpyTIe7crS7Mw3q5lvCHkbxEKbnEUegI3QC5mfe5IFxmMmSQGQ5opb3oJPn-PTi_DjLJr1WZVYC-P4IdYbbrgyrL3GBS5kfbQhDf0mmgkHOAzmF1O1EA992TBHpaltq4qMWV7Ip7OBd9ZnR8OJ9z3Rb_DyPlq17ubkMfk6XKjLMrmctI2cqKtfOBz_75_skEc9CqXvndrskgem3CPjM0dj3R3S801VVn1Ix_RsQ3Dd7ZGHbq-PuhKmJ-TH8XJu-R6qwlDXBBwcIq1yqoQu5m1xd33TDADZaGr7AlK5qkpMtF5Qs8TCkAUe4nuEmsqOfm9FaevfwBpTS4pcwthV3QxjLfpdTFpUGtOd7Ne761tTXnWFASl8NQ2TzbEApqqrlQT3SiFUEN1TcnFyfP7h1OsbQXgKA2gvCSJhFJ_6EYSHLGVKc-6LMDTKj40xkdI6TrQEbCqZDtAqCdS6NBBsqoRv-DOyVcJlviA0jVUO4pxpQIqhTmQodJ6Dk04DCfrMR-TdoBSZ6lnSsVnHInP8ziyDp5Xh0xqRN2vJpWMG-YPMwaBXWW8b6owBzEzB0voxDLH-GVY13mJRmqpFGYzVIbiNRuS508f1JCxF0sYAzh5brfrr7BlYePx8-a-C-2Qb8GDiMuEOyFazas0rwFyNfG1X10-pIDMw |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6VcgAJ8SiUBgosEgqXOrXXj9jihFCrAG1VoVTKAcnal6VAbKexfXBP_QlI_BD-U38JM7txovKQECfb8njXj9mZb9Y73xDyyou40hkLHQAbgRMwN3ME87TDdJwAIM2kb3gLjk-i0VnwYRJONsibLhfG8kOsJtxwZBh7jQMcJ6T316yhX3g98AEP3yA3saC3iac-rbmjksQUVkXOLCfwh5OOedZl-92V133RbwDzOl41DufwHvnc3apdZ_J10NRiIC9-YXH8z2e5T-4ugSh9azXnAdnQxRbpn1om63aPjteJWdUe7dPTNcd1u0Xu2Ok-arOYHpIfB_OpoXwoc01tHXDwibTMqOQqnzb51eW3usPIWlFTGpCKRVngWusZ1XPMDZnhLv5KqKho6XnDC5MCBwaZGl7kAtouq7pra7acyKR5qXDFkzm8uvyui4s21yCFf6ehsynmwJRVuRDgYSlEC7x9RM4OD8bvRs6yFoQjMYZ2Yi_kWvpDN4QIkSVMKt93eRBo6UZa61AqFcVKADwVTHlomDgqXuJxNpTc1f422SzgNncITSKZgbjPFIDFQMUi4CrLwE8nngCV9nvkdacVqVwSpWO9jllqKZ5ZCl8rxa_VIy9XknNLDvIHmd1OsdKleahSBkgzAWPrRtDE6jQMbHzFvNBlgzIYrkN8G_bIY6uQq05YgryNHlzdN2r1195TMPK4ffKvgi_IrdH4-Cg9en_y8Sm5DfAwtgvjdslmvWj0M4BgtXhuhtpPkNM3Sw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF1BkRAS4lIoBAosEgovdWqvL7EfEW1UblWEWikSD9beLAViO8T2g_vUT0DiQ_infgkzu3aicpEQT3GU8a5jz86cWc-cIeSFF3GlMxY6ADYCJ2Bu5gjmaYfpOAFAmknf8BZ8OI6OToO3s3DWZVViLYzlh1hvuOHKMPYaF_hSZfsb0tDPvB75AIevkmtB5Mao0QcfN9RRSWL6qiJllhP441lPPOuy_f7My67oN3x5Ga4afzO5TT71V2rTTL6MmlqM5NkvJI7_91fukFsdDKWvrN7cJVd0sU2GU8tj3e7Rk01ZVrVHh3S6Ybhut8lNu9lHbQ3TPfLjcDk3hA9lrqntAg4ekZYZlVzl8ya_OP9W9whZK2oaA1KxKgvMtF5QvcTKkAUe4ouEioqWfm14YQrgwBxTw4pcwNhlVfdjLbptTJqXCvOdzNeL8--6OGtzDVL4bhomm2MFTFmVKwH-lUKswNv75HRyePL6yOk6QTgSI2gn9kKupT92Q4gPWcKk8n2XB4GWbqS1DqVSUawEgFPBlIdmiaPaJR5nY8ld7e-QrQIu8yGhSSQzEPeZAqgYqFgEXGUZeOnEE6DQ_oC87JUilR1NOnbrWKSW4Jml8LRSfFoD8nwtubTUIH-Q2e31Ku2MQ5UywJkJmFo3giHWP8OyxlvMC102KIPBOkS34YA8sPq4noQlyNrowdlDo1V_nT0FE4-fj_5V8Bm5Pj2YpO_fHL97TG4ANoxtVtwu2apXjX4C-KsWT81C-wkBKTYD |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epiproteome+profiling+of+cadmium%E2%80%90transformed+human+bronchial+epithelial+cells+by+quantitative+histone+post%E2%80%90translational+modification%E2%80%93enzyme%E2%80%90linked+immunosorbent+assay&rft.jtitle=Journal+of+applied+toxicology&rft.au=Zhan%E2%80%90Ling+Liang&rft.au=Dan%E2%80%90Dan+Wu&rft.au=Yao%2C+Yue&rft.au=Fei%E2%80%90Yuan+Yu&rft.date=2018-06-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0260-437X&rft.eissn=1099-1263&rft.volume=38&rft.issue=6&rft.spage=888&rft.epage=895&rft_id=info:doi/10.1002%2Fjat.3597&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0260-437X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0260-437X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0260-437X&client=summon |